Jussara M do Carmo Selected Research

Jussara M do Carmo Research Topics

Disease

24	Hypertension (High Blood Pressure) 01/2022 - 04/2008
20	Body Weight (Weight, Body) 01/2022 - 08/2012
20	Obesity 01/2021 - 09/2009
8	Weight Gain 01/2022 - 03/2013
5	Insulin Resistance 01/2021 - 03/2015
4	Diabetes Mellitus 01/2022 - 03/2015
4	Heart Failure 01/2022 - 01/2020
4	Myocardial Infarction 01/2021 - 01/2014
3	Inflammation (Inflammations) 01/2021 - 03/2015
3	Weight Loss (Weight Reduction) 01/2019 - 01/2014
3	Hyperphagia (Overeating) 01/2018 - 01/2017
2	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 01/2020
2	Ventricular Remodeling 01/2022 - 01/2021
2	Albuminuria 01/2022 - 10/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 05/2011
2	Hypercapnia 01/2019 - 08/2012
2	Fatty Liver 01/2018 - 01/2018
2	Hyperglycemia 01/2017 - 11/2008
2	Bradycardia 01/2015 - 11/2008
2	Tachycardia (Tachyarrhythmias) 01/2014 - 11/2008
1	Glucose Intolerance 01/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Infarction (Infarctions) 01/2021
1	Cicatrix (Scar) 01/2021
1	Edema (Dropsy) 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Morbid Obesity 10/2017
1	Polyuria 01/2017
1	Dyslipidemias (Dyslipidemia) 03/2015
1	Chronic Renal Insufficiency 01/2014

Drug/Important Bio-Agent (IBA)

24	LeptinIBA 01/2021 - 11/2008
13	MelanocortinsIBA 01/2021 - 04/2008
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2008
8	SodiumIBA 01/2021 - 06/2010
7	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2015
7	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2019 - 06/2010
5	AldosteroneIBA 01/2021 - 10/2012
5	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2019 - 09/2009
4	Insulin (Novolin)FDA Link 10/2021 - 06/2015
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 10/2012
4	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 03/2015
4	Angiotensin IIIBA 01/2021 - 01/2015
4	CytokinesIBA 01/2021 - 10/2012
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 12/2014
4	Hormones (Hormone)IBA 01/2017 - 06/2010
3	salicylhydroxamic acid (SHAM)IBA 11/2018 - 01/2014
2	Transient Receptor Potential ChannelsIBA 01/2022 - 01/2022
2	TRPC6 Cation ChannelIBA 01/2022 - 01/2022
2	FructoseIBA 01/2021 - 01/2018
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2021 - 03/2015
2	Natriuretic AgentsIBA 01/2019 - 10/2012
2	SHU 9119IBA 01/2019 - 08/2013
2	Type 3 Melanocortin ReceptorIBA 01/2016 - 02/2014
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2015 - 01/2014
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2015 - 01/2014
2	SaltsIBA 10/2012 - 09/2009
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 10/2021
1	phospholambanIBA 01/2021
1	BW 10IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	empagliflozinIBA 01/2021
1	Type 1 Angiotensin ReceptorIBA 01/2021
1	Dimethyl FumarateIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Sirtuin 3IBA 01/2021
1	CollagenIBA 01/2021
1	SymportersIBA 01/2021
1	Rosiglitazone (Avandia)FDA Link 01/2020
1	PPAR gammaIBA 01/2020
1	NestinIBA 10/2019
1	CD36 AntigensIBA 10/2019
1	GlucocorticoidsIBA 01/2019
1	AdipokinesIBA 01/2019
1	Leptin ReceptorsIBA 01/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	CatecholaminesIBA 10/2017
1	Hexamethonium (Hexamethonium Bromide)IBA 01/2017
1	AlbuminsIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 10/2015
1	LipidsIBA 10/2015
1	Adenosine Triphosphate (ATP)IBA 10/2015
1	CreatinineIBA 10/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2015
1	Tyrosine (L-Tyrosine)FDA Link 12/2014
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 12/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013
1	GhrelinIBA 04/2013

Therapy/Procedure

6	Therapeutics 01/2021 - 03/2013
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Ovariectomy (Oophorectomy) 11/2018
1	Denervation 02/2014
1	Caloric Restriction 01/2014
1	Ligation 01/2014